TY - JOUR
T1 - HEBM-assisted SSR synthesis of copper-doped ZnO nanocrystalline semiconductors
T2 - physical properties, dielectric behavior and enhanced antimicrobial efficacy against clinically relevant pathogens
AU - Al-Shammari, Zurayfah
AU - Massoudi, Imen
AU - Rached, Amani
AU - Ababutain, Ibtisam
AU - Ibrahim Alghamdi, Azzah
AU - Abdullah Algarou, Norah
AU - Adel Amin, Kamal
AU - Kotb, Essam
AU - Ben Ali, Amor
N1 - Publisher Copyright:
© 2025 Imam Abdulrahman Bin Faisal University. Published by Informa UK Limited, trading as Taylor & Francis Group.
PY - 2025
Y1 - 2025
N2 - This study explores copper-doped zinc oxide nanoparticles (Cu–ZnO NPs) synthesized via high-energy ball milling–assisted solid-state reaction, optimizing particle size, doping (3–9 wt.% Cu), medium state (solid/liquid), and visible-light activation for antimicrobial efficacy. Structural analysis (XRD, SEM, TEM/EDS) confirmed hexagonal wurtzite ZnO with Cu²⁺ lattice integration, uniform dopant distribution, and particle refinement to ~50 nm post-milling. Bandgap reduction (0.13 eV) enhanced charge mobility and ROS generation. Solid-state NPs exhibited superior antimicrobial activity, achieving inhibition zones of 14.8 mm (Staphylococcus aureus) and 19.7 mm (Staphylococcus epidermidis), outperforming liquid-phase results (p < 0.05). Light activation amplified ROS production, elevating Candida albicans inhibition to 23.0 mm. Size reduction enabled unprecedented inhibition of gram-negative Klebsiella oxytoca (12.4 mm). The synergy of Cu doping, particle refinement, and light activation underscores Cu–ZnO NPs as scalable, tunable antimicrobial agents against resistant pathogens, with potential applications in clinical and industrial settings.
AB - This study explores copper-doped zinc oxide nanoparticles (Cu–ZnO NPs) synthesized via high-energy ball milling–assisted solid-state reaction, optimizing particle size, doping (3–9 wt.% Cu), medium state (solid/liquid), and visible-light activation for antimicrobial efficacy. Structural analysis (XRD, SEM, TEM/EDS) confirmed hexagonal wurtzite ZnO with Cu²⁺ lattice integration, uniform dopant distribution, and particle refinement to ~50 nm post-milling. Bandgap reduction (0.13 eV) enhanced charge mobility and ROS generation. Solid-state NPs exhibited superior antimicrobial activity, achieving inhibition zones of 14.8 mm (Staphylococcus aureus) and 19.7 mm (Staphylococcus epidermidis), outperforming liquid-phase results (p < 0.05). Light activation amplified ROS production, elevating Candida albicans inhibition to 23.0 mm. Size reduction enabled unprecedented inhibition of gram-negative Klebsiella oxytoca (12.4 mm). The synergy of Cu doping, particle refinement, and light activation underscores Cu–ZnO NPs as scalable, tunable antimicrobial agents against resistant pathogens, with potential applications in clinical and industrial settings.
KW - antimicrobial activity
KW - clinically relevant pathogens
KW - Copper-doped ZnO nanoparticles
KW - high-energy ball milling (HEBM)
KW - reactive oxygen species (ROS)
KW - solid-state reaction (SSR)
UR - https://www.scopus.com/pages/publications/105006428484
U2 - 10.1080/10667857.2025.2509992
DO - 10.1080/10667857.2025.2509992
M3 - Article
AN - SCOPUS:105006428484
SN - 1066-7857
VL - 40
JO - Materials Technology
JF - Materials Technology
IS - 1
M1 - 2509992
ER -